The observed anti-cancer effects of PIAS2b-dsRNAi in both thyroid and non-thyroid anaplastic cells, including downregulation of PLK1, gTub, CDK1, and the presence of high-molecular weight PP2CA and PSMC5 bands, might be linked to this dysregulated proteasome activity. The gene discussed is CDK1; the disease is cancer.